Page 342 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 342

328     SECTION IV  Drugs with Important Actions on Smooth Muscle


                 TABLE 18–1  Eicosanoid receptors. 1

                  Receptor       Endogenous   Secondary    G Protein; Second
                  (Human)        Ligand      Ligands       Messenger            Major Phenotype(s) in Knockout Mice

                  DP 1           PGD 2                     G s ; ↑cAMP          ↓Allergic asthma
                                                                                ↑Inflammatory cardiovascular disease, hypertension,
                                                                                thrombosis
                                                                2+
                                                           G i ; ↑Ca , ↓cAMP    ↑Allergic airway inflammation
                  DP 2           PGD 2       15d-PGJ 2           i
                                                                                ↓Cutaneous inflammation
                  EP 1           PGE 2       PGI 2         G q ; ↑Ca 2+ i       ↓Colon carcinogenesis
                                                           G s ; ↑cAMP          Impaired fertilization
                  EP 2           PGE 2
                                                                                Salt-sensitive hypertension
                                                                                ↓Tumorgenesis
                                                           G i ; ↓cAMP, ↑Ca 2+  Resistance to pyrogens
                  EP 3 I, II, III, IV, V, VI, e, f  PGE 2             i
                                                           G s ; ↑cAMP          ↓Acute cutaneous inflammation
                                                           G q ; ↑PLC, ↑Ca 2+ i  ↑Allergic airway inflammation
                                                           G 12/13 ; Rho activation  Obesity
                                                           G s ; ↑cAMP          ↑Myocardial infarction severity
                  EP 4           PGE 2
                                                                                ↑Intestinal inflammatory/immune response
                                                                                ↓Colon carcinogenesis
                                                                                Patent ductus arteriosus
                  FP A,B         PGF 2α      isoPs         G q ; ↑PLC, ↑Ca 2+ i  Parturition failure
                                                           G 12/13 ; Rho activation  ↓Basal blood pressure; ↑Vasopressor response
                                                                                ↓Atherosclerosis
                  IP            PGl 2        PGE 2         Gs; ↑cAMP            ↑Thrombotic response
                                                                                ↑Response to vascular injury
                                                                                ↑Atherosclerosis
                                                                                ↑Cardiac fibrosis
                                                                                Salt-sensitive hypertension
                                             isoPs         G q ,G 12/13 ,G 16 ; ↑PLC,   ↑Bleeding time
                  TP α,β         TXA 2
                                                              2+
                                                           ↑Ca , Rho activation
                                                               i
                                                                                ↓Response to vascular injury
                                                                                ↓Atherosclerosis
                                                                                ↑Survival after cardiac allograft
                                                                  2+
                                                           G 16 ,G i ; ↑Ca , ↓cAMP  Inflammatory responses
                  BLT 1          LTB 4                              i
                                                                                ↓Insulin resistance in obesity
                  BLT 2          LTB 4       12(S)-HETE    G q -like, G i -like, G 12 -like,   ↓inflammatory arthritis
                                                              2+
                                                           ↑Ca  i
                                             12(R)-HETE                         ↑Experimental colitis
                                                           G q ; ↑PLC, ↑Ca 2+   ↓Innate and adaptive immune vascular permeability
                  CysLT 1        LTD 4       LTC 4 /LTE 4             i
                                                                                response
                                                                                ↑Pulmonary inflammatory and fibrotic response
                                                           G q ; ↑PLC, ↑Ca 2+   ↓Pulmonary inflammatory and fibrotic response
                  CysLT 2        LTC 4 /LTD 4  LTE 4                  i
                 1
                 Splice variants for the eicosanoid receptors are indicated where appropriate.
                  2+
                 Ca , intracellular calcium; cAMP, cyclic adenosine 3’,5’-monophosphate; PLC, phospholipase C; isoPs, isoprostanes; 15d-PGJ 2 , 15-deoxy-Δ 12,14 -PGJ 2 .
                   i
   337   338   339   340   341   342   343   344   345   346   347